Anteris Technologies grants contingent options and PSUs to executives, options to McDonnell

Anteris Technologies Global Corp. disclosed in an 8-K that its board took several equity compensation actions on September 12, 2026. The company set up a contingent option package with 1,200,000 nonqualified employee stock options approved for Wayne Paterson and 414,000 for David St Denis, both dated to grant on September 13, 2026, with an exercise price set at fair market value on that date and an expiration ten years later on September 13, 2036.¹

These option awards will not take effect unless shareholders sign off, since the effectiveness of the Contingent Option Grants is contingent on and subject to stockholder approval.¹ Vesting follows a standard schedule, as the grants generally vest in substantially equal installments over the first four anniversaries of the grant date, contingent on continued employment.¹ Special vesting rules apply for death, disability, and termination scenarios, including different treatment for Paterson versus St Denis under specific "cause" and "good reason" definitions.

The board also approved performance-based restricted stock units, granting 800,000 PSUs to Paterson and 485,000 PSUs to St Denis¹, also subject to stockholder approval. These units vest based on stock price hurdles, with 30% vesting if the volume-weighted average price hits $21.50, another 30% at $41.00, and the final 40% at $61.50¹ over five years.

Separately, Matthew McDonnell received a stock option grant covering the right to purchase CHESS Depositary Interests, valued at a target of $500,000, with the same September 13, 2026 grant date and September 13, 2036 expiration, priced at the CDI's fair market value on the grant date¹. Unlike the executive grants, McDonnell's award vests over three years and was not described as contingent on shareholder approval. The filing was signed by CEO Wayne Paterson on September 17, 2026.